Altogether, data differentiate DEspR+actNs as a targetable neutrophil-subset associated with ARDS and COVID19-ARDS severity, and suggest DEspR-inhibition as a potential therapeutic paradigm. The gene discussed is FBXW7-AS1; the disease is acute respiratory distress syndrome.